Musta hyppynaru kulutusta kestävällä muovipinnoitteella — recall SR/04442/25
EU Safety Gate (RAPEX) · Finland · 2025-12-26 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
🔴 Serious hazard — Reported risk: Tuotteen muovimateriaalissa on liian korkea pitoisuus bis(2-etyyliheksyyli)ftalaattia (DEHP), di-isobutyyliftalaattia (DIBP) ja dibutyyliftalaattia (DBP) (mitatut arvot: 0,26 %, 0,35 % ja 13 painoprosenttia). Nämä ftalaatit voivat vahingoittaa terveyttä aiheuttamalla mahdollisia vaurioita lisääntymiselimille. Tuote ei täytä REACH-asetuksen vaatimuksia.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
09/09/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Black jump rope with wear-resistant plastic coating
Risk Description (original English): The plastic material of the product has an excessive concentration of bis(2-ethylhexyl) phthalate (DEHP), diisobutyl phthalate (DIBP) and dibutyl phthalate (DBP) (measured values: 0,26 %, 0,35% and 13% by weight, respectively). These phthalates may harm the health by causing possible damage to the reproductive system.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.